Stonebridge Capital Advisors LLC Amgen Inc Transaction History

Stonebridge Capital Advisors LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$218.65 - $271.46 $37,826 - $46,962	-173 Reduced 41.59%	243 $65,000
Q2 2023 Aug 23, 2023	BUY	$214.27 - $253.37 $7,285 - $8,614	34 Added 8.9%	416 $92,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $115,152 - $140,352	-510 Reduced 57.17%	382 $92,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $17,864 - $22,698	78 Added 9.58%	892 $234,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $8,978 - $10,126	40 Added 5.17%	814 $183,000
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $13,611 - $15,147	-59 Reduced 7.08%	774 $188,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $3,727 - $4,123	-17 Reduced 2.0%	833 $201,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $994 - $1,138	-5 Reduced 0.58%	850 $191,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $11,674 - $13,678	55 Added 6.88%	855 $182,000
Q2 2021 Aug 20, 2021	SELL	$233.58 - $259.14 $10,744 - $11,920	-46 Reduced 5.44%	800 $195,000
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $187,735 - $218,775	846 New	846 $210,000
Q4 2020 Mar 05, 2021	SELL	$216.38 - $257.67 $183,706 - $218,761	-849 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $5,934 - $7,282	-30 Reduced 3.41%	849 $200,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $5,467 - $7,251	30 Added 3.53%	879 $178,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $7,000 - $8,998	-37 Reduced 4.18%	849 $205,000
Q2 2019 Aug 15, 2019	BUY	$166.7 - $195.41 $147,696 - $173,133	886 New	886 $163,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.